Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
24/11 Stock Alert -------- SOMX
0 views
Skip to first unread message
Vincent
Nov 24, 2009, 10:31:34 AM11/24/09
to
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses
on the in-licensing and development of proprietary product candidates for
the treatment of diseases and disorders in the fields of psychiatry and
neurology. The company has completed four Phase III clinical trials for its
lead product candidate, Silenor (doxepin hydrochloride) for the treatment of
insomnia. Somaxon Pharmaceuticals, Inc. was founded in 2003 and is
headquartered in San Diego, California.
0 new messages